Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice
Nifuroxazide (NAZ), a nitrofuran derivative used to treat diarrhea, has been recently shown to possess anticancer activity. However, its pharmacokinetic profile is poorly known. The pharmacokinetic profile of NAZ was thus investigated in mice using a newly developed method based on high-performance...
Main Authors: | Tommaso Ceruti, Quintino Giorgio D’Alessandris, Roberta Frapolli, Jay Gopalakrishnan, Mariachiara Buccarelli, Marina Meroni, Liverana Lauretti, Lucia Ricci-Vitiani, Roberto Pallini, Massimo Zucchetti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/10/2071 |
Similar Items
-
Effectiveness and safety of «Nifuroxazide-ECO» in therapy of escherichioses in children
by: N. V. Gonchar, et al.
Published: (2021-03-01) -
Nifuroxazide Pharmaceutical Preparations in the Russian Federation. Publication One: Nomenclature, Chemical and Pharmaceutical Characteristics of the Preparations’ Composition
by: V. I. Kocherovets, et al.
Published: (2021-10-01) -
Nifuroxazide Prevents Chikungunya Virus Infection Both <i>In Vitro</i> and <i>In Vivo</i> via Suppressing Viral Replication
by: Yangang Liu, et al.
Published: (2024-08-01) -
Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling
by: Mohamed El-Sherbiny, et al.
Published: (2021-11-01) -
Pharmacokinetic Characterization of the DDAH1 Inhibitors ZST316 and ZST152 in Mice Using a HPLC-MS/MS Method
by: Arduino A. Mangoni, et al.
Published: (2022-02-01)